These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28357703)

  • 1. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities, treatment and outcome.
    Mitsikostas DD; Ljubisavljevic S; Deligianni CI
    J Headache Pain; 2017 Dec; 18(1):40. PubMed ID: 28357703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical clonazepam for burning mouth syndrome: Is it efficacious in patients with anxiety or depression?
    Rossella I; Alessandro V; Naman R; Gary K; Hervé SY
    J Oral Rehabil; 2022 Jan; 49(1):54-61. PubMed ID: 34716948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of criteria-based diagnosis of burning mouth syndrome on treatment outcome.
    Danhauer SC; Miller CS; Rhodus NL; Carlson CR
    J Orofac Pain; 2002; 16(4):305-11. PubMed ID: 12455431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome.
    Arduino PG; Cafaro A; Garrone M; Gambino A; Cabras M; Romagnoli E; Broccoletti R
    Lasers Med Sci; 2016 May; 31(4):811-6. PubMed ID: 26873501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS).
    Ko JY; Kim MJ; Lee SG; Kho HS
    Arch Gerontol Geriatr; 2012; 55(3):755-61. PubMed ID: 22040716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Burning mouth syndrome].
    Schatton R; Riechelmann H
    Laryngorhinootologie; 2007 Jun; 86(6):454-60; quiz 461-2. PubMed ID: 17541900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy evaluation of clonazepam for symptom remission in burning mouth syndrome: a meta-analysis.
    Cui Y; Xu H; Chen FM; Liu JL; Jiang L; Zhou Y; Chen QM
    Oral Dis; 2016 Sep; 22(6):503-11. PubMed ID: 26680638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and non-pharmacological management of burning mouth syndrome: A systematic review.
    Reyad AA; Mishriky R; Girgis E
    Dent Med Probl; 2020; 57(3):295-304. PubMed ID: 33113291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.
    Zborowski J; Konopka T
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of clonazepam in patients with burning mouth syndrome and various symptoms or psychological conditions.
    Shin HI; Bang JI; Kim GJ; Kim MR; Sun DI; Kim SY
    Sci Rep; 2023 May; 13(1):7257. PubMed ID: 37142613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study.
    Fenelon M; Quinque E; Arrive E; Catros S; Fricain JC
    Int J Oral Maxillofac Surg; 2017 Nov; 46(11):1505-1511. PubMed ID: 28473243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose naltrexone for treatment of burning mouth syndrome.
    Sangalli L; Miller CS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Apr; 135(4):e83-e88. PubMed ID: 35851249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
    Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burning mouth syndrome: a systematic review of treatments.
    Liu YF; Kim Y; Yoo T; Han P; Inman JC
    Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of reticular oral lichen planus patients with burning mouth syndrome-like oral symptoms: a pilot study.
    Adamo D; Mignogna MD; Pecoraro G; Aria M; Fortuna G
    J Dermatolog Treat; 2018 Sep; 29(6):623-629. PubMed ID: 29308937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome.
    Grushka M; Epstein J; Mott A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):557-61. PubMed ID: 9830647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of burning mouth syndrome: systematic review and management recommendations.
    Patton LL; Siegel MA; Benoliel R; De Laat A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S39.e1-13. PubMed ID: 17379153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of treatment modalities in burning mouth syndrome-A systematic review.
    Ślebioda Z; Lukaszewska-Kuska M; Dorocka-Bobkowska B
    J Oral Rehabil; 2020 Nov; 47(11):1435-1447. PubMed ID: 32979878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burning mouth syndrome after taking clonazepam.
    Culhane NS; Hodle AD
    Ann Pharmacother; 2001; 35(7-8):874-6. PubMed ID: 11485137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effective perospirone augmentation with clonazepam for treatment-resistant burning mouth syndrome: A case report.
    Watanabe M; Takao C; Maeda C; Nayanar G; Tominaga R; Kimura Y; Tu TTH; Nagamine T; Toyofuku A
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):464-467. PubMed ID: 38500267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.